Upcoming System Maintenance

Notice:Promega will be performing essential system updates January 21–25.

Order processing and shipping will pause starting January 21 at 4:00 PM CST and resume on January 26.
Please plan to order in advance for any products needed during this timeframe.

Please contact Customer Service with any questions.
Phone: (608) 274-4330
Toll-Free Phone: (800) 356-9526
Email: custserv@promega.com
Hours: 8am-5pm CST, Monday-Friday

Citations Search

Sort By:

SLAS Technol. 24, 28–40. Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy. 2019

Wilson K.M., Mathews-Griner L.A., Williamson T., Guha R., Chen L., Shinn P., McKnight C., Michael S., Klumpp-Thomas C., Binder Z.A., Ferrer M., Gallia G.L., Thomas C.J., Riggins G.J.

Notes: Researchers generated novel glioblastoma 3D cell models to better predict drug efficacy in patients. Two cell lines were used for high-throughput screening, where cell viability and apoptosis assays were used. (5224)

Expand Full Notes »

Cell Death Dis. 7, e2492. Large-scale pharmacological profiling of 3D tumor models of cancer cells 2016

Mathews Griner L.A., Zhang X., Guha R., McKnight C., Goldlust I.S., Lal-Nag M., Wilson K., Michael S., Titus S., Shinn P., Thomas C.J., Ferrer M.

Notes: In this study, researchers used high-throughput compatible 384-well and 1536-well assay plate formats with spheroids of various cell types. Viability and apoptosis of monolayer and 3D tumor models was assessed. (5223)

Expand Full Notes »